Clinical trial
Effect of Itopride on Semaglutide Gastroparesis
Recruiting now · Phase 4 · 1 countries · Registry ID NCT07254715
What this study is about
Semaglutide delays gastric emptying and increases the risk of aspiration with anesthesia; So, the addition of prokinetics as Itopride, could enhance gastric emptying and hasten surgery. The investigator will evaluate the effect of Itopride on Semaglutide-induced gastroparesis and residual gastric contents after 8 hours of fasting by gastric ultrasound before anesthesia.
Basic eligibility
Full registry criteria
Treatments and study arms
Itopride HCI 50 mg
Daily oral 50mg Itopride tablet TID, 1 hour before meals for 7 days
Placebo
Daily placebo tablet TID, 1 hour before meals for 7 days
Primary outcomes
Residual gastric contents (clear fluid ˃1.5 mL/kg or the presence of solids) by ultrasound in the right lateral decubitus after 8-hours fasting .
Study locations
1 locations were listed when this page was built. The first 40 are shown.